Circumvent Pharmaceuticals Inc is a Portland-based company dedicated to developing precision medicines for neurodegenerative diseases, with a particular focus on Batten Disease. They have assembled a team of experienced scientists and clinicians who utilize high-fidelity animal models and a clear clinical development path to uncover new insights into brain-cell dysfunction common to various neurological diseases.
By investigating the palmitoylome and its effects on synaptic function, Circumvent aims to develop therapeutic strategies for modulating palmitoylation, which has the potential to yield medicines for both rare and common forms of neurodegenerative disease. Their priority is to meet the needs of patients through the development of precision medicines for rare neurological disorders, with a current focus on CLN1 Batten Disease.
Generated from the website